This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

No Significant Event

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 03/08/2022
Location: Virtual
Subject: New Era of Smarter Food Safety Update; Partnership for Food Protection 2022 National Workshop
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Officials from federal, state, local, tribal, and territorial regulatory and public health agencies

Event Date: 03/10/2022
Location: Virtual
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several executives from across the consumer associations, and scientific and technical staff from industry

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Jacqueline O'Shaughnessy, Acting Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 03/08/2022
Location: Virtual
Subject: America’s Blood Centers 60th Annual Meeting; FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, regulatory organizations, and other stakeholders

Event Date: 03/08/2022
Location: Virtual
Subject: 5th Annual Gene Therapy for Rare Disorders Conference; Rare Disease Gene Therapy Development: Where Has It Been and Where Is It Going?
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees from industry, regulatory organizations, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 03/11/2022
Location: Virtual
Subject: Cardiovascular Disease Prevention
FDA Participant/Group: ROBIN MCKINNON;
Non FDA Participant/Group: Kalin Stovall, Laura Cobb, Marci Nielsen, Nicole Ide, Tom Frieden (Resolve to Save Lives);

Event Date: 03/11/2022
Location: Virtual
Subject: Check In on Food Issues
FDA Participant/Group: KARI BARRETT;
Non FDA Participant/Group: Leslie Sarasin (Food Marketing Institute);

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 03/09/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: MARGARET OELLER; WILLIAM FLYNN; ANNA O'BRIEN; ANTONIA MONIQUE SENNETT; MATTHEW LUCIA; CRYSTAL GROESBECK; AMY OMER;
Non FDA Participant/Group: Representatives of the American Sheep Industry Association (ASIA)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event